Molecular mechanism underlying Akt activation in zinc-induced cardioprotection.

Our previous study demonstrated that zinc prevents cardiac reperfusion injury by targeting the mitochondrial permeability transition pore (mPTP) via Akt and glycogen synthetase kinase 3beta (GSK-3beta). We aimed to address the mechanism by which zinc activates Akt. Treatment of H9c2 cells with ZnCl(2) (10 microM) in the presence of the zinc ionophore pyrithione (4 microM) for 20 min enhanced Akt phosphorylation (Ser(473)), indicating that zinc can rapidly activate Akt. Zinc did not alter either phosphatase and tensin homolog deleted on chromosome 10 (PTEN) phosphorylation and total PTEN protein levels or PTEN oxidation, implying that PTEN may not play a role in the action of zinc. However, zinc-induced Akt phosphorylation was blocked by both the nonselective receptor tyrosine kinase (RTK) inhibitor genistein and the selective insulin-like growth factor-1 RTK (IGF-1RTK) inhibitor AG1024, indicating that zinc activates Akt via IGF-1RTK. Zinc-induced phosphorylation of protein tyrosine and Ser/Thr was also abolished by AG1024. In addition, zinc markedly enhanced phosphorylation of IGF-1 receptor (IGF-1R), which was again reversed by genistein and AG1024. A confocal imaging study revealed that AG1024 abolished the preventive effect of zinc on oxidant-induced mPTP opening, confirming that IGF-1RTK plays a role in zinc-induced cardioprotection. Furthermore, zinc decreased the activity of protein phosphatase 2A (PP2A), a major protein Ser/Thr phosphatase, implying that protein Ser/Thr phosphatases may also play a role in the action of zinc on Akt activity. Taken together, these findings demonstrate that exogenous zinc activates Akt via IGF-1RTK and prevents the mPTP opening in cardiac cells. Inactivation of Ser/Thr protein phosphatases may also contribute to zinc-induced Akt activation.

[1]  M. Mocanu,et al.  Letter to the editor: "Zinc and cardioprotection: the missing link". , 2009, American journal of physiology. Heart and circulatory physiology.

[2]  A. Ougolkov,et al.  Inhibition of glycogen synthase kinase-3. , 2008, Methods in molecular biology.

[3]  C. Lau,et al.  Both EGFR kinase and Src-related tyrosine kinases regulate human ether-à-go-go-related gene potassium channels. , 2008, Cellular signalling.

[4]  R. Mueller,et al.  Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3beta. , 2008, American journal of physiology. Heart and circulatory physiology.

[5]  S. Robboy,et al.  Differential Expression of Receptor Tyrosine Kinases (RTKs) and IGF-I Pathway Activation in Human Uterine Leiomyomas , 2008, Molecular medicine.

[6]  Peter P. Liu,et al.  Aldosterone induces elastin production in cardiac fibroblasts through activation of insulin-like growth factor-I receptors in a mineralocorticoid receptor-independent manner. , 2007, The American journal of pathology.

[7]  L. Klotz,et al.  Stimulation of phosphoinositide 3-kinase/Akt signaling by copper and zinc ions: mechanisms and consequences. , 2007, Archives of biochemistry and biophysics.

[8]  R. Mueller,et al.  NO mobilizes intracellular Zn2+ via cGMP/PKG signaling pathway and prevents mitochondrial oxidant damage in cardiomyocytes. , 2007, Cardiovascular research.

[9]  M. Boutjdir,et al.  Protective Role of Intracellular Zinc in Myocardial Ischemia/Reperfusion Is Associated with Preservation of Protein Kinase C Isoforms , 2007, Journal of Pharmacology and Experimental Therapeutics.

[10]  M. Mocanu,et al.  PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury? , 2007, British Journal of Pharmacology.

[11]  R. Novak,et al.  The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression. , 2007, Pharmacology & therapeutics.

[12]  L. Graves,et al.  Inhibition of protein tyrosine phosphatase activity mediates epidermal growth factor receptor signaling in human airway epithelial cells exposed to Zn2+. , 2006, Toxicology and applied pharmacology.

[13]  Arne Gericke,et al.  Regulation of the PTEN phosphatase. , 2006, Gene.

[14]  P. Linsdell,et al.  Tyrosine kinase and phosphatase regulation of slow delayed‐rectifier K+ current in guinea‐pig ventricular myocytes , 2006, The Journal of physiology.

[15]  D. Yellon,et al.  Survival kinases in ischemic preconditioning and postconditioning. , 2006, Cardiovascular research.

[16]  G. Semenza,et al.  PTEN Activity Is Modulated During Ischemia and Reperfusion: Involvement in the Induction and Decay of Preconditioning , 2005, Circulation research.

[17]  Y. Whang,et al.  p38 and EGF receptor kinase-mediated activation of the phosphatidylinositol 3-kinase/Akt pathway is required for Zn2+-induced cyclooxygenase-2 expression. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[18]  W. Engeland,et al.  Zone-specific cell proliferation during adrenocortical regeneration after enucleation in rats. , 2005, American journal of physiology. Endocrinology and metabolism.

[19]  W. Maret,et al.  Fluctuations of cellular, available zinc modulate insulin signaling via inhibition of protein tyrosine phosphatases. , 2005, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[20]  B. Winblad,et al.  Zinc-induced anti-apoptotic effects in SH-SY5Y neuroblastoma cells via the extracellular signal-regulated kinase 1/2. , 2005, Brain research. Molecular brain research.

[21]  K. Mensah,et al.  Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten? , 2005, Journal of the American College of Cardiology.

[22]  L. Klotz,et al.  Phosphoinositide 3-kinase signaling in the cellular response to oxidative stress , 2005, Biological chemistry.

[23]  I. Norota,et al.  Differential action of a protein tyrosine kinase inhibitor, genistein, on the positive inotropic effect of endothelin‐1 and norepinephrine in canine ventricular myocardium , 2005, British journal of pharmacology.

[24]  M. Crackower,et al.  The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. , 2004, Journal of molecular and cellular cardiology.

[25]  D. Yellon,et al.  New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. , 2004, Cardiovascular research.

[26]  W. Maret,et al.  Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling. , 2003, Experimental cell research.

[27]  C. Downes,et al.  Redox regulation of PI 3‐kinase signalling via inactivation of PTEN , 2003, The EMBO journal.

[28]  Y. Whang,et al.  Zinc-induced PTEN Protein Degradation through the Proteasome Pathway in Human Airway Epithelial Cells* , 2003, Journal of Biological Chemistry.

[29]  J. Sham,et al.  Effects of pharmacological preconditioning with U50488H on calcium homeostasis in rat ventricular myocytes subjected to metabolic inhibition and anoxia , 2002, British journal of pharmacology.

[30]  B. Neel,et al.  Receptor-Specific Regulation of Phosphatidylinositol 3′-Kinase Activation by the Protein Tyrosine Phosphatase Shp2 , 2002, Molecular and Cellular Biology.

[31]  Woojin Jeong,et al.  Reversible Inactivation of the Tumor Suppressor PTEN by H2O2 * , 2002, The Journal of Biological Chemistry.

[32]  W. Lopaczynski,et al.  Autophosphorylation of the insulin-like growth factor I receptor cytoplasmic domain. , 2000, Biochemical and biophysical research communications.

[33]  B. Vanhaesebroeck,et al.  The PI3K-PDK1 connection: more than just a road to PKB. , 2000, The Biochemical journal.

[34]  E. Fischer.  Cell signaling by protein tyrosine phosphorylation. , 1999, Advances in enzyme regulation.

[35]  B. Hemmings,et al.  Regulation of protein kinase cascades by protein phosphatase 2A. , 1999, Trends in biochemical sciences.

[36]  P. Cohen,et al.  Novel protein serine/threonine phosphatases: variety is the spice of life. , 1997, Trends in biochemical sciences.

[37]  Denise Grady.  Quick-Change Pathogens Gain an Evolutionary Edge , 1996, Science.

[38]  J. Berg,et al.  The Galvanization of Biology: A Growing Appreciation for the Roles of Zinc , 1996, Science.

[39]  K. Lau,et al.  Phosphotyrosyl protein phosphatases. , 1989, The Biochemical journal.

[40]  P. Bornstein,et al.  Phosphotyrosyl-protein phosphatase. Specific inhibition by Zn. , 1981, The Journal of biological chemistry.